Facilitating Transition to Recommended PTSD Treatment
ConditionPTSD
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorVA Office of Research and Development
About this trial
Cognitive processing therapy (CPT) and prolonged exposure therapy (PE) were widely disseminated as recommended posttraumatic stress disorder (PTSD) treatments. However, post-9/11 Veterans with PTSD rarely initiate CPT or PE, especially as an initial treatment. Little research has explored the combinations and sequences of psychosocial and medication treatments that Veterans receive ("treatment sequences"). One common and understudied treatment sequence begins with stabilization treatment, which is designed to prepare Veterans for CPT or PE. There is a significant research gap in understanding how treatment sequence affects initiation of CPT or PE. The proposed research is an innovative, mixed-methods approach to assessing the impact of variability in treatment sequence, including stabilization treatment, on initiation of CPT or PE and applying this knowledge by developing a health services intervention that facilitates timely transition to CPT or PE. Research aims can improve PTSD treatment by increasing initiation of and reducing disparities in CPT/PE.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Veteran
Diagnosed with PTSD as part of an intake assessment at the San Francisco Veterans Affairs Medical Center
Disqualifiers
Inability to provide informed consent
Cognitive impairment that precludes comprehension of study materials
Active psychosis
Trial design
Design model
Parallel
Treatments tested in this trial
Treatment As Usual
BehavioralCare Coordination Treatment as usual with a VA mental health treatment coordinator
New Health Services Intervention
BehavioralThe experimental care coordination intervention begins with a 60-minute in-person session and continues with regular, brief contacts between the Veteran and clinician. During the first session, the clinician and Veteran will (1) discuss the Veteran's beliefs about their presenting problem; (2) collaboratively identify SMART goals; (3) discuss treatment options; (4) use shared decision-making to match treatment to SMART goals; (5) develop criteria to evaluate treatment progress; and (6) manage treatment expectations. During follow-up sessions, the clinician and Veteran will reflect on treatment progress, make appropriate updates to SMART goals, and re-evaluate barriers to CPT or PE.
Treatment groups
40 Participants
are divided into 2 treatment groupsGroup A: TAUActive comparator 1 intervention
Group B: New Health Services InterventionExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Initiation of Recommended PTSD Treatment
Patient self-report or documentation in the electronic health record of initiating either cognitive processing therapy (CPT) or prolonged exposure therapy (PE).
Time frame
Through study completion, an average of 1 yearSecondary outcomes
1
Acceptability (Discontinuation of Mental Health Treatment without Provider Concurrence)
Patient self-report or documentation in the electronic health record that a patient has discontinued all mental health treatment without provider concurrence.
Time frame
Through study completion, an average of 1 year2
Limited Efficacy Testing (PTSD Symptom Severity)
Self-Reported PTSD Symptom Severity as assessed by the PTSD Checklist for DSM-5.
Time frame
Through study completion, an average of 1 yearSponsors and contacts
Click on the lead sponsor to view all of their trials.
VA Office of Research and Development
Lead sponsor
White River Junction Veterans Affairs Medical Center
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: